(Q33349004)

26 July 2017

1 reference

title

Drug-induced myelosuppression : diagnosis and management (English)

1 reference

26 July 2017

Peter J Carey

1

1 reference

26 July 2017

1 January 2003

1 reference

26 July 2017

1 reference

26 July 2017

26

1 reference

26 July 2017

10

1 reference

26 July 2017

691-706

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200326100-00003

26 July 2017

0 references

cites work

An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan

1 reference

12 December 2020

Chloromycetin, an Antibiotic With Chemotherapeutic Activity in Experimental Rickettsial and Viral Infections

1 reference

12 December 2020

Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes

1 reference

12 December 2020

Ocular chloramphenicol and aplastic anaemia. Is there a link?

1 reference

12 December 2020

Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation

1 reference

12 December 2020

The pathophysiology of acquired aplastic anemia

1 reference

12 December 2020

Hematologic consequences of chloramphenicol therapy

1 reference

12 December 2020

Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics

1 reference

12 December 2020

Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia

1 reference

12 December 2020

HSP70-2 9.0 kb variant is in linkage disequilibrium with the HLA-B and DRB1* alleles associated with clozapine-induced agranulocytosis

1 reference

12 December 2020

Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Bl

1 reference

12 December 2020

Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor

1 reference

12 December 2020

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

1 reference

12 December 2020

Drug-induced mitochondrial damage and sideroblastic change.

1 reference

12 December 2020

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

1 reference

12 December 2020

Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia

1 reference

12 December 2020

Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidence

1 reference

12 December 2020

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

1 reference

12 December 2020

Rare adverse reactions to nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia

1 reference

12 December 2020

Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors

1 reference

12 December 2020

Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force

1 reference

12 December 2020

Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.

1 reference

12 December 2020

Concordance for drug-induced aplastic anemia in identical twins

1 reference

12 December 2020

Lack of evidence for systemic toxicity following topical chloramphenicol use.

1 reference

12 December 2020

Drug-induced agranulocytosis

1 reference

12 December 2020

Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients

1 reference

12 December 2020

Aplastic anemia in Israel: evaluation of the etiological role of chloramphenicol on a community-wide basis

1 reference

12 December 2020

Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia

1 reference

12 December 2020

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

1 reference

12 December 2020

Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study

1 reference

12 December 2020

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force

1 reference

12 December 2020

Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose

1 reference

12 December 2020

A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy

1 reference

12 December 2020

Drug-induced megaloblastic change.

1 reference

12 December 2020

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

12 December 2020

Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF)

1 reference

12 December 2020

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum

1 reference

12 December 2020

The new generation of antiepileptic drugs: advantages and disadvantages

1 reference

12 December 2020

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

12 December 2020

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

1 reference

12 December 2020

Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis

1 reference

12 December 2020

Gold-induced aplastic anemia

1 reference

12 December 2020

Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia

1 reference

12 December 2020

Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia

1 reference

12 December 2020

Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis

1 reference

12 December 2020

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

1 reference

12 December 2020

The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases.

1 reference

12 December 2020

Linezolid and reversible myelosuppression

1 reference

12 December 2020

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

1 reference

12 December 2020

Clozapine: the commitment to patient safety

1 reference

12 December 2020

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

1 reference

12 December 2020

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

1 reference

12 December 2020

Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

1 reference

12 December 2020

Acquired pure red cell aplasia

1 reference

12 December 2020

Pharmacogenetics and adverse drug reactions

1 reference

12 December 2020

Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force

1 reference

12 December 2020

Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Filgrastim (r-metHuG-CSF) reversal of drug-induced agranulocytosis

1 reference

12 December 2020

The treatment of severe acquired aplastic anemia.

1 reference

12 December 2020

Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party

1 reference

12 December 2020

Stem cells in normal growth and disease

1 reference

12 December 2020

Immune and toxic mechanisms in drug-induced agranulocytosis.

1 reference

12 December 2020

Guidelines on the provision of facilities for the care of adult patients with haematological malignancies (including leukaemia and lymphoma and severe bone marrow failure). British Committee for Standards in Haematology Clinical Haematology Task For

1 reference

12 December 2020

An increased HLA DR2 frequency is seen in aplastic anemia patients

1 reference

12 December 2020

Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis

1 reference

12 December 2020

Elaboration: drug-induced agranulocytosis--monitoring antithyroid treatment

1 reference

12 December 2020

Filgrastim treatment of three patients with clozapine-induced agranulocytosis

1 reference

12 December 2020

Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.

1 reference

12 December 2020

A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations

1 reference

12 December 2020

Development of the Clozaril Patient Management System

1 reference

12 December 2020

Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years

1 reference

12 December 2020

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

12 December 2020

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

1 reference

12 December 2020

Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.

1 reference

12 December 2020

Guidelines for the clinical use of red cell transfusions

1 reference

12 December 2020

Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring

1 reference

12 December 2020

Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia

1 reference

12 December 2020

Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic

1 reference

12 December 2020

Aplastic anemia in soldiers treated with atabrine (quinacrine).

1 reference

12 December 2020

Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings

1 reference

12 December 2020

The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups

1 reference

12 December 2020

Allogenic bone marrow transplantation for leukemias and aplastic anemia

1 reference

12 December 2020

Drug-induced agranulocytosis

1 reference

12 December 2020

An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia

1 reference

12 December 2020

Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia

1 reference

12 December 2020

The role of granulocyte colony-stimulating factor in cancer chemotherapy

1 reference

12 December 2020

Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy

1 reference

12 December 2020

A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia

1 reference

12 December 2020

Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid

1 reference

12 December 2020

Thiopurine methyltransferase levels should be measured before commencing patients on azathioprine

1 reference

12 December 2020

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

1 reference

12 December 2020

Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia

1 reference

12 December 2020

Mechanisms of clozapine-induced agranulocytosis

1 reference

12 December 2020

Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel

1 reference

12 December 2020

10.2165/00002018-200326100-00003

Identifiers

DOI

1 reference

PubMed ID

12862504

Dimensions Publication ID

26 July 2017

0 references

1 reference

PubMed ID

12862504